The weekly litigation news digest is live. Subscribe now

IP Verse

Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use Thereof - EP3170842

The patent EP3170842 was granted to Cafa Therapeutics on Sep 4, 2019. The application was filed on Jul 15, 2015 under application number EP15821331A. The patent is currently recorded with a legal status of "Revoked".

EP3170842

CAFA THERAPEUTICS
Application Number
EP15821331A
Filing Date
Jul 15, 2015
Status
Revoked
Apr 27, 2024
Publication Date
Sep 4, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
BIONTECH CELL & GENE THERAPIESJun 4, 2020WILKADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTCN103483453
INTERNATIONAL-SEARCH-REPORTCN103820393
INTERNATIONAL-SEARCH-REPORTWO2007059997
INTERNATIONAL-SEARCH-REPORTWO2013051718
OPPOSITIONCN103483453
OPPOSITIONEP2765193
OPPOSITIONEP3099706
OPPOSITIONEP3294333
OPPOSITIONWO2014075788
OPPOSITIONWO2015113576
OPPOSITIONWO2016008405
OPPOSITIONWO2016180468
OPPOSITIONWO2016180782
SEARCHWO2005113587
SEARCHWO2012038055
SEARCHWO2015113576

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents